Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. Long Term Debt 2015–2025
Seres Therapeutics, Inc. annual long term debt history from 2019 to 2023. Long term debt refers to financial obligations that are due more than one year in the future.
- Seres Therapeutics, Inc. long term debt as of December 31, 2023: 110.0M, a 120.00% increase year-over-year.
- Seres Therapeutics, Inc. long term debt for 2023 were 110.0M, a 120.00% increase from 2022.
- Seres Therapeutics, Inc. long term debt for 2022 were 50.0M, a 107.89% increase from 2021.
- Seres Therapeutics, Inc. long term debt for 2021 were 24.1M, a 3.80% decrease from 2020.
- Seres Therapeutics, Inc. long term debt for 2020 were 25.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Seres Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2023 | $110 |
| 2022 | $50 |
| 2021 | $24 |
| 2020 | $25 |
| 2019 | $25 |
Seres Therapeutics, Inc. Long Term Debt — FAQ
Seres Therapeutics, Inc. (MCRB) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's long term debt history?
The chart and table above show Seres Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.